Rosmarinic acid

• Supplier: R&D Systems
• Catalog: 0630
• Prices: $139.00
• Sizes: 50 mg
• Cas Number: 20283-92-5
• Chemical Name: [R-(+)]-α-[[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxybenzenepropanoicacid
• Formula: C18H16O8
• Molecular Weight: 360.32
• Purity: >99%

Product References

Rosmarinic acid inhibits external oxidative effects of human polymorphonuclear - Rosmarinic acid inhibits external oxidative effects of human polymorphonuclear

van Kessel KP, Kalter ES, Verhoef J. Agents Actions. 1986 Jan;17(3-4):375-6.

Modification of endotoxin-induced haemodynamic and haematological changes in the - Modification of endotoxin-induced haemodynamic and haematological changes in the

Bult H, Herman AG, Rampart M. Br J Pharmacol. 1985 Feb;84(2):317-27.

Inhibition of complement by covalent attachment of rosmarinic acid to activated - Inhibition of complement by covalent attachment of rosmarinic acid to activated

Sahu A, Rawal N, Pangburn MK. Biochem Pharmacol. 1999 Jun 15;57(12):1439-46.

Complement-dependent stimulation of prostacyclin biosynthesis: inhibition by - Complement-dependent stimulation of prostacyclin biosynthesis: inhibition by

Rampart M, Beetens JR, Bult H, Herman AG, Parnham MJ, Winkelmann J. Biochem Pharmacol. 1986 Apr 15;35(8):1397-400.

Multiple tyrosine metabolites are GPR35 agonists. - Multiple tyrosine metabolites are GPR35 agonists.

Deng H, Hu H, Fang Y. Sci Rep. 2012;2:373.